Baxalta Now Part Of Shire

This early-stage trial is testing a single injection of gene therapy for adults with hemophilia B. The goal is to see if the treatment is safe and if it can help the body produce its own missing clotting factor, potentially reducing or eliminating the need for regular injections.…

This study is monitoring the long-term safety of ADYNOVI/ADYNOVATE, a medication for hemophilia A, in 207 patients who are already using it as part of their regular care. The main goal is to check for any side effects that might develop over time, especially those affecting the k…